This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Eran Maoz, MD; Ehud Grossman, MD; Michael Thaler, MD; Talma Rosenthal, MD

Arch Intern Med. 1992;152(12):2503-2504.

Abstract
A patient with epilepsy controlled by carbamazepine developed a carbamazepine neurotoxic reaction after being given an increased dosage of diltiazem hydrochloride as adjunctive therapy. Abrupt withdrawal of diltiazem reduced the circulating carbamazepine concentration and resulted in an epileptic attack. Awareness of the interaction between diltiazem and carbamazepine and careful monitoring of carbamazepine blood levels is recommended to prevent the dangerous neurotoxic effect associated with this combination.

(Arch Intern Med. 1992;152:2503-2504)

Author Affiliations
From the Department of Medicine D (Drs Maoz, Grossman, Thaler, and Rosenthal) and Chorley Hypertension Institute (Drs Grossman and Rosenthal), Chaim Sheba Medical Center, Tel Hashomer, Israel; and Tel Aviv (Israel) University Sackler School of Medicine (Drs Grossman and Rosenthal).

Footnotes
Accepted for publication March 11, 1992.

Reprint requests to Chorley Hypertension Institute, Hypertension Unit, Chaim Sheba Medical Center, Tel Hashomer 65521, Israel (Dr Rosenthal).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?